DEFB124
gene geneOn this page
Also known as DEFB-24
Summary
DEFB124 (defensin beta 124, HGNC:18104) is a protein-coding gene on chromosome 20q11.21, encoding Beta-defensin 124 (Q8NES8). Has antibacterial activity.
Defensins are cysteine-rich cationic polypeptides that are important in the host immunologic response to invading microorganisms. This antimicrobial protein is secreted and is a member of the beta defensin protein family. Beta defensin genes are found in several clusters throughout the genome, with this gene mapping to a cluster at 20q11.1. The encoded protein may serve to enhance innate immunity in the prostate.
Source: NCBI Gene 245937 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001037500
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18104 |
| Approved symbol | DEFB124 |
| Name | defensin beta 124 |
| Location | 20q11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DEFB-24 |
| Ensembl gene | ENSG00000180383 |
| Ensembl biotype | protein_coding |
| Entrez | 245937 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000317676, ENST00000481595
RefSeq mRNA: 1 — MANE Select: NM_001037500
NM_001037500
CCDS: CCDS33457
Canonical transcript exons
ENST00000317676 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001276984 | 31465471 | 31465663 |
| ENSE00001470126 | 31472956 | 31473038 |
| ENSE00003917273 | 31474627 | 31475127 |
Expression profiles
Bgee: expression breadth ubiquitous, 155 present calls, max score 96.89.
Top tissues by expression
234 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 96.89 | gold quality |
| oviduct epithelium | UBERON:0004804 | 94.32 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 86.27 | gold quality |
| right testis | UBERON:0004534 | 85.64 | gold quality |
| fallopian tube | UBERON:0003889 | 85.52 | gold quality |
| left testis | UBERON:0004533 | 84.62 | gold quality |
| mucosa of stomach | UBERON:0001199 | 83.76 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 82.80 | gold quality |
| bronchial epithelial cell | CL:0002328 | 82.48 | gold quality |
| testis | UBERON:0000473 | 81.94 | gold quality |
| bronchus | UBERON:0002185 | 81.53 | gold quality |
| left uterine tube | UBERON:0001303 | 79.29 | gold quality |
| seminal vesicle | UBERON:0000998 | 79.27 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 78.88 | gold quality |
| lower esophagus | UBERON:0013473 | 78.62 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 78.39 | silver quality |
| secondary oocyte | CL:0000655 | 77.83 | silver quality |
| endocervix | UBERON:0000458 | 77.81 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 77.59 | gold quality |
| endometrium | UBERON:0001295 | 77.48 | gold quality |
| gingival epithelium | UBERON:0001949 | 77.39 | silver quality |
| subcutaneous adipose tissue | UBERON:0002190 | 76.56 | gold quality |
| decidua | UBERON:0002450 | 76.50 | gold quality |
| omental fat pad | UBERON:0010414 | 76.40 | gold quality |
| peritoneum | UBERON:0002358 | 76.35 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 75.89 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 75.43 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 75.19 | silver quality |
| tibial nerve | UBERON:0001323 | 74.99 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 74.91 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.31 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): NFKB, RELA
Literature-anchored findings (GeneRIF, showing 1)
- The encoded protein is thought to display antimicrobial activity and may enhance innate immunity in the prostate. (PMID:24955228)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Defb25 | ENSMUSG00000074678 |
| rattus_norvegicus | Defb25 | ENSRNOG00000036895 |
Paralogs (19): DEFB127 (ENSG00000088782), DEFB129 (ENSG00000125903), DEFB118 (ENSG00000131068), DEFB104A (ENSG00000176782), DEFB104B (ENSG00000177023), DEFB125 (ENSG00000178591), DEFB123 (ENSG00000180424), DEFB119 (ENSG00000180483), DEFB108B (ENSG00000184276), DEFB128 (ENSG00000185982), DEFB131A (ENSG00000186146), DEFB132 (ENSG00000186458), DEFB121 (ENSG00000204548), DEFB134 (ENSG00000205882), DEFB135 (ENSG00000205883), DEFB108C (ENSG00000215371), DEFB116 (ENSG00000215545), DEFB115 (ENSG00000215547), DEFB131B (ENSG00000225805)
Protein
Protein identifiers
Beta-defensin 124 — Q8NES8 (reviewed: Q8NES8)
Alternative names: Beta-defensin 24, Defensin, beta 124
All UniProt accessions (1): Q8NES8
UniProt curated annotations — full annotation on UniProt →
Function. Has antibacterial activity.
Subcellular location. Secreted.
Similarity. Belongs to the beta-defensin family.
RefSeq proteins (1): NP_001032589* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR025933 | Beta_defensin_dom | Domain |
Pfam: PF13841
UniProt features (5 total): disulfide bond 3, signal peptide 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NES8-F1 | 78.00 | 0.18 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 27–54, 34–48, 38–55
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-1461957 | Beta defensins |
| R-HSA-1461973 | Defensins |
MSigDB gene sets: 74 (showing top):
GOBP_RESPONSE_TO_NITROGEN_COMPOUND, REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_MYELOID_LEUKOCYTE_MIGRATION, GOBP_CELL_CHEMOTAXIS, GOBP_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS, GOBP_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_REGULATION_OF_LEUKOCYTE_MIGRATION, GOBP_LEUKOCYTE_CHEMOTAXIS, GOBP_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION, GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS, GOBP_TAXIS, GOBP_LEUKOCYTE_MIGRATION, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM
GO Biological Process (3): defense response to bacterium (GO:0042742), innate immune response (GO:0045087), defense response (GO:0006952)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Defensins | 1 |
| Antimicrobial peptides | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| defense response | 1 |
| response to bacterium | 1 |
| immune response | 1 |
| defense response to symbiont | 1 |
| response to stress | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
310 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DEFB124 | DEFB125 | Q8N687 | 806 |
| DEFB124 | DEFB128 | Q7Z7B8 | 802 |
| DEFB124 | DEFB135 | Q30KP9 | 801 |
| DEFB124 | DEFB127 | Q9H1M4 | 700 |
| DEFB124 | DEFB134 | Q4QY38 | 655 |
| DEFB124 | DEFB114 | Q30KQ6 | 618 |
| DEFB124 | DEFB123 | Q8N688 | 559 |
| DEFB124 | DEFB116 | Q30KQ4 | 551 |
| DEFB124 | DEFB129 | Q9H1M3 | 541 |
| DEFB124 | DEFB113 | Q30KQ7 | 509 |
| DEFB124 | CHST13 | Q8NET6 | 504 |
| DEFB124 | DEFB126 | Q9BYW3 | 496 |
| DEFB124 | GNG10 | P50151 | 478 |
| DEFB124 | SPATA3 | Q8NHX4 | 478 |
| DEFB124 | PROZ | P22891 | 468 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NCK2 | DEFB124 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PGRMC1 | DEFB124 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NCK2 | DEFB124 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PGRMC1 | DEFB124 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (5): DEFB124 (Two-hybrid), DEFB124 (Two-hybrid), DEFB124 (Affinity Capture-MS), DEFB124 (Cross-Linking-MS (XL-MS)), ANXA2 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A4H202, A4H203, A4H204, A4H206, A4H209, A4H211, A4H212, A4H213, A4H225, A4H227, A8MXU0, O19039, O89117, P0C8A5, P0C8A6, P0C8A7, Q30KJ3, Q30KK4, Q30KK6, Q30KL6, Q30KN8, Q30KP6, Q30KP8, Q32P86, Q32ZF3, Q32ZG3, Q32ZG7, Q32ZH5, Q32ZH6, Q32ZH9, Q32ZI2, Q4QY38, Q5IAB3, Q5IAB9, Q5J5C9, Q5J5Z9, Q5J600, Q5J602, Q6GXJ1, Q6IV23
Diamond homologs: Q30KK4, Q30KN4, Q30KN8, Q30KP9, Q32P86, Q32ZG7, Q8NES8, A4H241, Q5J5Z9, Q30KJ4, Q30KK6, Q32ZG2, Q5J5C9, Q5J600, A4H225, A4H226, A4H227, A4H228, A4H243, A4H244, A4H245, Q30KK2, Q30KK8, Q30KT5, Q5J602, Q8K3I8, Q8N690, Q9BEE3, Q9BYW3, A4H239, Q30KK3, Q8N687
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
680 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:31476467:G:GT | donor_gain | 1.0000 |
| 20:31476751:G:T | donor_gain | 1.0000 |
| 20:31475455:G:GT | donor_gain | 0.9900 |
| 20:31476751:G:GT | donor_gain | 0.9900 |
| 20:31476491:C:T | donor_gain | 0.9800 |
| 20:31476721:G:GT | donor_gain | 0.9800 |
| 20:31476721:G:T | donor_gain | 0.9800 |
| 20:31465661:TCCC:T | acceptor_loss | 0.9600 |
| 20:31465664:C:A | acceptor_loss | 0.9600 |
| 20:31465665:T:G | acceptor_loss | 0.9600 |
| 20:31472950:TGTTA:T | donor_loss | 0.9600 |
| 20:31472951:GTTA:G | donor_loss | 0.9600 |
| 20:31472952:TTA:T | donor_loss | 0.9600 |
| 20:31472953:TACCT:T | donor_loss | 0.9600 |
| 20:31472954:ACC:A | donor_loss | 0.9600 |
| 20:31472955:C:CA | donor_loss | 0.9600 |
| 20:31475362:CCGAG:C | donor_loss | 0.9600 |
| 20:31475363:CGAG:C | donor_loss | 0.9600 |
| 20:31475365:AG:A | donor_loss | 0.9600 |
| 20:31475366:GG:G | donor_loss | 0.9600 |
| 20:31475367:GTAA:G | donor_loss | 0.9600 |
| 20:31475368:T:A | donor_loss | 0.9600 |
| 20:31475456:A:T | donor_gain | 0.9600 |
| 20:31465662:CC:C | acceptor_gain | 0.9500 |
| 20:31465663:CC:C | acceptor_gain | 0.9500 |
| 20:31471600:C:A | donor_gain | 0.9500 |
| 20:31472378:C:CT | acceptor_gain | 0.9500 |
| 20:31475433:G:GT | donor_gain | 0.9500 |
| 20:31465664:C:CC | acceptor_gain | 0.9400 |
| 20:31472368:G:T | acceptor_gain | 0.9400 |
AlphaMissense
448 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:31465638:C:A | W28C | 0.920 |
| 20:31465638:C:G | W28C | 0.920 |
| 20:31465650:G:C | F24L | 0.887 |
| 20:31465650:G:T | F24L | 0.887 |
| 20:31465652:A:G | F24L | 0.887 |
| 20:31465561:C:G | C54S | 0.843 |
| 20:31465562:A:T | C54S | 0.843 |
| 20:31465580:A:G | C48R | 0.835 |
| 20:31465642:C:G | C27S | 0.820 |
| 20:31465643:A:T | C27S | 0.820 |
| 20:31465609:C:G | C38S | 0.817 |
| 20:31465610:A:T | C38S | 0.817 |
| 20:31465579:C:G | C48S | 0.815 |
| 20:31465580:A:T | C48S | 0.815 |
| 20:31465628:C:A | G32W | 0.814 |
| 20:31465560:G:C | C54W | 0.803 |
| 20:31465579:C:T | C48Y | 0.803 |
| 20:31465643:A:G | C27R | 0.803 |
| 20:31465558:C:G | C55S | 0.802 |
| 20:31465559:A:T | C55S | 0.802 |
| 20:31465561:C:T | C54Y | 0.802 |
| 20:31465609:C:T | C38Y | 0.802 |
| 20:31465562:A:G | C54R | 0.799 |
| 20:31465608:G:C | C38W | 0.791 |
| 20:31465621:C:T | C34Y | 0.789 |
| 20:31465618:T:G | Q35P | 0.787 |
| 20:31465628:C:G | G32R | 0.787 |
| 20:31465628:C:T | G32R | 0.787 |
| 20:31465647:T:A | K25N | 0.779 |
| 20:31465647:T:G | K25N | 0.779 |
dbSNP variants (sampled 300 via entrez): RS1000200096 (20:31469042 A>C), RS1000330657 (20:31469315 C>A), RS1000433540 (20:31474165 T>C), RS1000668277 (20:31473247 G>A,C,T), RS1001186369 (20:31475486 G>T), RS1002725021 (20:31469512 G>C), RS1002892424 (20:31467713 G>A), RS1003634920 (20:31468936 G>A), RS1004335720 (20:31468271 T>C), RS1004434328 (20:31468754 C>A,T), RS1004490294 (20:31476431 C>G,T), RS1004765457 (20:31472472 G>A), RS1005291816 (20:31465751 C>A,T), RS1006437464 (20:31473930 C>T), RS1006459 (20:31476528 A>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation | 2 |
| aflatoxin B2 | increases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression, affects cotreatment | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Lipopolysaccharides | affects cotreatment, affects response to substance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.